candoxatril has been researched along with Hypertension in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 10 (71.43) | 18.2507 |
2000's | 3 (21.43) | 29.6817 |
2010's | 1 (7.14) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lang, CC; Singh, JS | 1 |
Hercule, H; Newaz, MA; Oyekan, A; Truong, L; Yousefipour, Z | 1 |
Jakovski, K; Jovanoska, E; Kostova, E; Maleska, V; Slaninka-Miceska, M; Zafirov, D | 1 |
Hayakawa, H; Hirata, Y; Kangawa, K; Matsuo, H; Matsuoka, H; Sugimoto, T; Suzuki, E | 1 |
Goto, A; Hayakawa, H; Hirata, Y; Kangawa, K; Kimura, K; Matsuo, H; Minamino, N; Omata, M; Suzuki, E; Suzuki, Y | 1 |
Armstrong, R; Finn, WL; Gordon, RD; Klemm, SA; Stowasser, M; Tunny, TJ; Ziesak, MD | 1 |
Wilkins, MR | 1 |
Crozier, IG; Espiner, EA; Nicholls, MG; Richards, AM; Yandle, TG | 1 |
Crozier, IG; Espiner, EA; Frampton, C; Ikram, H; Richards, AM; Wittert, GA; Yandle, TG | 1 |
Ikuse, T; Kuro, T; Matsumura, Y; Nose, M; Okahara, A | 1 |
Connell, JM; Davidson, G; Jardine, AG; O'Connell, JE | 1 |
Buckley, MG; MacGregor, GA; Markandu, ND; Sagnella, GA; Singer, DR | 1 |
Bevan, EG; Carmichael, HA; Connell, JM; Davies, DL; Doyle, J; Lorimer, AR; McInnes, GT | 1 |
Buckley, MG; MacGregor, GA; Markandu, ND; Miller, MA; Sagnella, GA; Singer, DR | 1 |
2 review(s) available for candoxatril and Hypertension
Article | Year |
---|---|
Angiotensin receptor-neprilysin inhibitors: clinical potential in heart failure and beyond.
Topics: Aminobutyrates; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biphenyl Compounds; Clinical Trials as Topic; Drug Combinations; Heart Failure; Humans; Hypertension; Indans; Natriuretic Peptide, Brain; Neprilysin; Propionates; Pyridines; Receptors, Angiotensin; Renin-Angiotensin System; Risk Factors; Stroke Volume; Tetrazoles; Thiazepines; Valsartan | 2015 |
Clinical potential of endopeptidase-24.11 inhibitors in cardiovascular disease.
Topics: Animals; Antihypertensive Agents; Cardiovascular Diseases; Cyclohexanecarboxylic Acids; Diuretics; Drug Design; Heart Failure; Humans; Hypertension; Indans; Neprilysin; Propionates; Protease Inhibitors; Thiorphan | 1993 |
7 trial(s) available for candoxatril and Hypertension
Article | Year |
---|---|
Inhibition of endopeptidase EC 3.4.24.11 by candoxatril lowered blood pressure and increased urinary but not plasma atrial natriuretic peptide in essential hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Pressure; Double-Blind Method; Female; Humans; Hypertension; Indans; Male; Middle Aged; Neprilysin; Propionates | 1993 |
Plasma brain natriuretic peptide and endopeptidase 24.11 inhibition in hypertension.
Topics: Adult; Aged; Angiotensin II; Atrial Natriuretic Factor; Double-Blind Method; Humans; Hypertension; Indans; Male; Methionine; Middle Aged; Natriuretic Peptide, Brain; Neprilysin; Nerve Tissue Proteins; Posture; Propionates; Time Factors | 1993 |
Chronic inhibition of endopeptidase 24.11 in essential hypertension: evidence for enhanced atrial natriuretic peptide and angiotensin II.
Topics: Adult; Angiotensin II; Atrial Natriuretic Factor; Blood Pressure; Double-Blind Method; Heart Rate; Humans; Hypertension; Indans; Kidney; Male; Middle Aged; Natriuresis; Neprilysin; Propionates; Time Factors | 1993 |
Candoxatril, an orally active neutral endopeptidase inhibitor, raises plasma atrial natriuretic factor and is natriuretic in essential hypertension.
Topics: Administration, Oral; Adult; Analysis of Variance; Antihypertensive Agents; Atrial Natriuretic Factor; Biological Availability; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hypertension; Indans; Male; Natriuresis; Neprilysin; Propionates | 1992 |
Is atrial natriuretic peptide-guanosine 3',5' cyclic monophosphate coupling a determinant of urinary sodium excretion in essential hypertension?
Topics: Atrial Natriuretic Factor; Cyclic GMP; Female; Humans; Hypertension; Indans; Male; Middle Aged; Natriuresis; Neprilysin; Propionates; Sodium, Dietary | 1992 |
Candoxatril, a neutral endopeptidase inhibitor: efficacy and tolerability in essential hypertension.
Topics: Antihypertensive Agents; Atrial Natriuretic Factor; Blood Pressure; Double-Blind Method; Female; Humans; Hypertension; Indans; Male; Middle Aged; Neprilysin; Propionates | 1992 |
Dietary sodium and inhibition of neutral endopeptidase 24.11 in essential hypertension.
Topics: Adult; Aldosterone; Analysis of Variance; Atrial Natriuretic Factor; Blood Pressure; Creatine; Heart Rate; Hematocrit; Humans; Hypertension; Indans; Middle Aged; Neprilysin; Potassium; Propionates; Renin; Sodium; Sodium, Dietary | 1991 |
5 other study(ies) available for candoxatril and Hypertension
Article | Year |
---|---|
Chronic endopeptidase inhibition in DOCA-salt hypertension: mechanism of cardiovascular protection.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Desoxycorticosterone; Endothelin-1; Hypertension; Indans; Kidney; Male; Models, Animal; Neprilysin; Nitric Oxide; Propionates; Rats; Rats, Sprague-Dawley; Sodium | 2003 |
Dual inhibition of angiotensin converting enzyme and neutral endopeptidase produces effective blood pressure control in spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Pressure; Drug Combinations; Enalapril; Hypertension; Indans; Male; Neprilysin; Propionates; Pyridines; Rats; Rats, Inbred SHR; Thiazepines | 2005 |
Mechanisms of the natriuretic effects of neutral endopeptidase inhibition in Dahl salt-sensitive and salt-resistant rats.
Topics: Animals; Atrial Natriuretic Factor; Blood Pressure; Dose-Response Relationship, Drug; Hypertension; Indans; Natriuresis; Natriuretic Peptide, Brain; Neprilysin; Nerve Tissue Proteins; Peptide Fragments; Propionates; Rats; Rats, Inbred Strains; Sodium, Dietary | 1994 |
Mechanisms underlying the augmented responses of deoxycorticosterone acetate-salt hypertensive rats to neutral endopeptidase inhibitors.
Topics: Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Base Sequence; Blood Pressure; Desoxycorticosterone; Hypertension; Indans; Male; Molecular Sequence Data; Neprilysin; Polysaccharides; Propionates; Rats; Rats, Wistar; Sodium Chloride; Thiorphan | 1994 |
Effects of SA7060, a novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme, on deoxycorticosterone acetate-salt-induced hypertension in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Blood Pressure; Body Weight; Cardiomegaly; Desoxycorticosterone; Enalapril; Heart; Hypertension; Hypertrophy; Indans; Kidney; Kidney Function Tests; Male; Naphthalenes; Neprilysin; Organ Size; Peptidyl-Dipeptidase A; Propionates; Rats; Rats, Sprague-Dawley; Urea | 2000 |